High- versus low-dose ACE inhibition in chronic heart failure: A double- blind, placebo-controlled study of imidapril

Journal of the American College of Cardiology

Volumn 32, Issue 7, 1998, Pages 1811-1818

  Van Veldhuisen, Dirk J ^a   Genth Zotz, Sabine ^b   Brouwer, Jan ^a   Boomsma, Frans ^c   Netzer, Tilo ^d   Man In 'T Veld, Arie J ^c   Pinto, Yigal M ^e   Lie, K I ^f   Crijns, Harry J g m ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MERCK KGAA   (Germany)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; NORADRENALIN; RENIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WORK CAPACITY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL NATRIURETIC FACTOR; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMIDAZOLES; IMIDAZOLIDINES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032420481     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00464-1     Document Type: Article

References (40)

1. Cohn J.N. The management of chronic heart failure. N Engl J Med. 335:1996;490-498.
2. Pitt B. ACE inhibitor co-therapy in patients with heart failure rationale for the randomized aldactone evaluation study (RALES) . Eur Heart J. 16:(Suppl N):1995;107-110.
3. Van Veldhuisen D.J., Charlesworth A., Hampton J.R., Crijns H.J.G.M. Large differences in drug treatment of chronic heart failure between the European countries. [abstract] J Am Coll Cardiol. 31:(Suppl A):1998;115A.
4. Cleland J.G.F., Poole-Wilson P.A. ACE inhibitors for heart failure a question of dose . Br Heart J. 72:(Suppl):1994;S106-S110.
5. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol. 28:1996;1323-1327.
6. Pitt B., Nicklas J.M. Target doses of ACE inhibitors in heart failure where should we aim? Eur Heart J. 19:1998;370-371.
7. Kubo M., Ochiai T., Kato J., Ishida R. Pharmacological studies on TA-6366, a new ACE-inhibitor: II. effect of long-term administration from the pre-hypertensive stage on blood pressure, relative heart weight and ACE-activity of various tissues in spontaneously hypertensive rats (SHRs). Jpn J Pharmacol. 57:1991;517-526.
8. Vandenburg M.J., MacKay E.M., Dews I., Pullan T., Brugier S. Dose-finding studies with imidapril - a new ACE inhibitor. Br J Clin Pharmacol. 37:1994;265-272.
9. Saruta T., Omae T., Kuramochi M., et al. Imidapril hydrochloride in essential hypertension a double-blind comparative study using enalapril maleate as a control . J Hypertens. 13:(Suppl 3):1995;S23-S30.
10. Narita H., Kaburaki M., Doi H., et al. Prolonging action of imidapril on the lifespan expectancy of cardiomyopathic hamsters. J Cardiovasc Pharmacol. 27:1996;861-871.
11. Mizino Y., Yashue H., Oshima S., et al. Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction. J Card Fail. 3:1997;287-293.
12. Pinto Y.M., Van Veldhuisen D.J., Tjon-Ka-Jie R.T., Rooks G., Netzer T., Lie K.I. Dose-finding study with imidapril, a novel angiotensin-converting enzyme inhibitor, in patients with stable chronic heart failure. Eur J Clin Pharmacol. 50:1996;265-268.
13. Rost R., Hollmann W. Belastungsuntersuchungen in der Praxis. Grundlagen, Technik und Interpretation ergometrischer Untersuchungsverfahren. 1982;82-85 Georg Thieme-Verlag, Stuttgart and New York.
14. Eugene M., Vandewalle H., Bertholon J.F., Teillac A. Arterial elasticity and physical working capacity in young men. J Appl Physiol. 61:1986;1720-1723.
15. Predel H.G., Rohden C., Heine O., Prinz U., Rost R.E. ACE inhibition and physical exercise studies on physical work capacity, energy metabolism, and maximal oxygen uptake in well-trained, healthy subjects . J Cardiovasc Pharmacol. 23:(Suppl 1):1994;S25-S28.
16. Van den Berg M.P., Crijns H.J.G.M., Gosselink A.T.M., et al. Chronotropic response to exercise in patients with atrial fibrillation relation to functional state . Br Heart J. 70:1993;150-153.
17. Hjemdal P., Daleskog M., Kana T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection comparison with a radioenzymatic method . Life Sci. 25:1979;131-138.
18. Derkx F.H.M., De Bruin R.J.A., Van Gool J.M.G., et al. Clinical validation of renin monoclonal-antibody based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem. 42:1996;1051-1063.
19. Van Veldhuisen D.J., Man in 't Veld A.J., Dunselman P.H.J.M., et al. Double-blind, placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure results of the Dutch Ibopamine Multicenter Trial (DIMT) . J Am Coll Cardiol. 22:1993;1564-1573.
20. Rodeheffer R.J., Lerman A., Heublein D.M., Burnett J.C. Jr. Increased plasma concentrations of endothelin in congestive heart failure. Mayo Clin Proc. 67:1988;719-724.
21. Cushman D.W., Cheung H.S. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochem Biophys Acta. 250:1971;261-265.
22. Nussberger J., Fleck E., Bahrmann H., Delius W., Schultheiss H.P., Brunner H.R. Dose-related effects of ACE inhibition in man quinapril in patients with moderate congestive heart failure . Eur Heart J. 15:(Suppl D):1994;113-122.
23. Bhaggoe U.M., Boomsma F., Admiraal P.J.J., Man in 't Veld A.J., Schalekamp M.A.D.H. Stability of human plasma atrial natriuretic peptide during storage at -80°C. Clin Chim Acta. 223:1993;179-184.
24. Davidson N.C., Coutie W.J., Webb D.J., Struthers A.D. Hormonal and renal differences between low- and high-dose angiotensin-converting enzyme inhibitor treatment in patients with chronic heart failure. Heart. 75:1996;576-581.
25. Struthers A.D. Ten years of natriuretic peptide research a new dawn for their diagnostic and therapeutic use? BMJ. 308:1994;1615-1619.
26. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction results of the SOLVD Echocardiographic Substudy . Circulation. 91:1995;2573-2581.
27. De Vries R.J.M., Van Veldhuisen D.J., Dunselman P.H.J.M., Van de Veer N., Crijns H.J.G.M. Physiologic parameters during initial stages of cardiopulmonary exercise testing in patients with chronic heart failure their value in the assessment of clinical severity and prognosis . Eur Heart J. 18:1997;1921-1930.
28. Francis G.S., Goldsmith S.R., Ziesche S., Nakajima H., Cohn J.N. Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. J Am Coll Cardiol. 5:1985;832-839.
29. Coats A.J.S. Interruption of the progression of heart failure are ACE inhibitors the solution? Cardiology. 87:(Suppl 1):1996;11-15.
30. Minshall R.D., Tan F., Nakamura F., et al. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. Circ Res. 81:1997;848-856.
31. Riegger G.A.J. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J. 12:1991;703-711.
32. Pacher R., Stanek B., Globits S., et al. Effects of two different enalapril doses on clinical, haemodynamic, and neurohumoral response of patients with severe congestive heart failure. Eur Heart J. 17:1996;1223-1232.
33. Clinical outcome with enalapril in symptomatic chronic heart failure a dose comparison . Eur Heart J. 19:1998;481-489.
34. Comparative effects of low-dose versus high-dose lisinopril on survival and major events in chronic heart failure the Assessment of Treatment with Lisinopril and Survival (ATLAS) Study . [abstract] Eur Heart J. 19:1998;142.
35. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353.
36. Buikema H., Pinto Y.M., Van Geel P.P., et al. Differential inhibition of plasma versus tissue ACE by utibapril biochemical and functional evidence for inhibition of vascular ACE activity . J Cardiovasc Pharmacol. 29:1997;684-691.
37. Van den Broek S.A.J., De Graeff P.A., Van Veldhuisen D.J., et al. Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure. J Card Fail. 3:1997;165-171.
38. Taher M.S., McLain L.G., McDonald K.M., et al. Effect of beta-adrenergic blockade on renin response to renal nerve stimulation. J Clin Invest. 57:1976;459-465.
39. Dzau V.J., Re R. Tissue angiotensin system in cardiovascular medicine a paradigm shift? [editorial] Circulation. 89:1994;493-498.
40. Hirsch A.T., Talsness C.E., Smith A.D., Schunkert H., Ingelfinger J.R., Dzau V.J. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation. 86:1992;1566-1574.